ArticleBlood and lymphatic cancer : targets and therapy

Idelalisib therapy of indolent B-cell malignancies: chronic lymphocytic leukemia and small lymphocytic or follicular lymphomas.

Yazan F Madanat et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.